info@seagull-health.com
SeagullHealth
语言:
search
new
Where to Purchase Lazertinib
505
Article source: Seagull Pharmacy
Dec 29, 2025
Lazertinib is an oral kinase inhibitor for combined use with Amivantamab, offering a novel treatment option for patients with advanced non-small cell lung cancer (NSCLC) harboring specific epidermal growth factor receptor (EGFR) mutations.

Where to Purchase Lazertinib

Overseas Purchase

(1) Patients may opt to consult and purchase Lazertinib at hospital pharmacies or licensed pharmacies in countries/regions where the drug has been marketed.(2) As drug prices may be affected by regional differences, exchange rate fluctuations and other factors, patients need to make a budget and plan in advance before purchase.

Purchase via Medical Service Institutions

(1) Patients may consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical enterprises.(2) Such institutions can usually provide legal import channels, along with professional consultation and guidance services.

Important Precautions for the Purchase and Administration of Lazertinib

Dosage and Administration

(1) The drug must be administered strictly in accordance with the dosage prescribed by the physician.

(2) The recommended dosage is 240 mg orally once daily, which may be taken with or without food.(3) Tablets should be swallowed whole; do not crush, split or chew the tablets.

Combination Therapy

(1) Lazertinib must be administered in combination with Amivantamab.

(2) If administered on the same day, Lazertinib may be taken at any time prior to the infusion of Amivantamab.

(3) It is imperative to understand and follow the complete dosing regimens for both drugs.

Management of Missed Doses and Vomiting

(1) If a dose is missed, take the missed dose as soon as possible within 12 hours of the scheduled time.(2) If more than 12 hours have elapsed, skip the missed dose and take the next dose at the regularly scheduled time.(3) If vomiting occurs after taking the drug, do not take an additional dose; the next dose should be taken at the scheduled time.

Management of Cutaneous Reactions

(1) Skin rash is a common adverse reaction associated with this combination regimen.(2) To reduce the incidence and severity of skin rash, physicians will recommend prophylactic oral antibiotics (e.g., doxycycline or minocycline) for 12 weeks starting on Day 1 of treatment.(3) Subsequently, antibiotic lotion should be applied to the scalp for 9 months. Non-comedogenic moisturizing cream should be used on the face and the entire body (excluding the scalp).(4) Wash hands and feet with 4% chlorhexidine solution daily. Sun protection measures should be strictly followed during treatment and for 2 months after the end of treatment.

How to Authenticate Lazertinib

Verify the External Packaging and Labeling of the Drug

(1) Approval Number and Labeling: Check whether the drug name, manufacturer and approval number printed on the drug carton are clear and standardized.(2) Anti-counterfeiting Features: Check for official anti-counterfeiting labels, laser marks or anti-counterfeiting codes. The packaging of genuine drugs features high-quality printing with clear fonts and distinct colors.

Verify the Physical Characteristics of the Tablets

(1) Dosage Strength and Appearance: Lazertinib is available in two dosage strengths. The 80 mg tablet is a yellow, oval, film-coated tablet, debossed with "LZ" on one side and "80" on the other side.(2) The 240 mg tablet is a reddish-purple, oval, film-coated tablet, debossed with "LZ" on one side and "240" on the other side.(3) Please check and confirm that the color, shape and debossed markings of the tablets are fully consistent with the official specifications (attached information), with no blurring, abrasion or abnormalities.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
What are the Indications for Lazertinib?
Lazertinib is an oral kinase inhibitor that received its first approval in the United States in 2024. In combination with Amivantamab, another medicinal product, it provides a novel treatment option f...
Dosage and Administration of Lazertinib, Recommended Dosage
Lazertinib is a kinase inhibitor indicated in combination with Amivantamab for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harbori...
Dosage and Administration, Recommended Dose of Flopropione Tablets (Cospanon)
Flopropione Tablets (Cospanon) is a medicine used to relieve spasms of the biliary tract, pancreas and urinary system. Clinically, it is commonly prescribed for biliary dyskinesia, cholelithiasis, cho...
What are the Precautions for Medication with Flopropione Tablets (Cospanon)?
Flopropione Tablets (Cospanon) is a drug indicated for relieving smooth muscle spasms of the hepatobiliary tract, pancreas and urinary system.What are the Precautions for Medication with Flopropione T...
What are the Precautions for Pretomanid Administration?
Pretomanid is an oral nitroimidazooxazine antimycobacterial agent. As part of a combination therapeutic regimen with bedaquiline and linezolid, it is specifically indicated for the treatment of specif...
Adverse Reactions of Pretomanid
Pretomanid is an oral nitroimidazooxazine antimycobacterial agent indicated for the treatment of pulmonary tuberculosis (TB) in adults with extensively drug-resistant (XDR) or multidrug-resistant (MDR...
Dosage and Administration of Voranidenib (Voranigo)
Voranidenib (Voranigo) is an oral inhibitor of isocitrate dehydrogenase-1 (IDH1) and isocitrate dehydrogenase-2 (IDH2). It is indicated for the treatment of adult patients and pediatric patients aged ...
What are the Indications of Voranidenib (Voranigo)?
Voranidenib (Voranigo) is a novel oral targeted therapy, which was first approved for marketing in the United States in 2024. As a dual inhibitor of isocitrate dehydrogenase-1 (IDH1) and isocitrate de...
Related Articles
Contraindications and Special Populations of Brensocatib Tablets
The prescribing information for Brixocatib tablets indicates that there are no absolute contraindications, but careful assessment of risks and benefits is still required in patients with special physi...
Dosage and Administration of Isatuximab Injection (Sarclisa)
Sarclisa must be administered under the supervision of a healthcare professional, and the administration site must be equipped with immediately available emergency equipment and medical support to man...
Indications and Dosage of Tepotinib
Tepotinib is an oral MET tyrosine kinase inhibitor indicated for the treatment of non-small cell lung cancer harboring MET exon 14 skipping mutations.I. Indications and Patient Selection1. Applicable ...
Dosage and Administration of Zidesamtinib
Before the first administration of Ziditnib, the following baseline assessments must be completed: serum creatine phosphokinase level, electrocardiogram, blood electrolytes (potassium, magnesium, calc...
Indications and Dosage and Administration of Ripretinib
Ripretinib is a kinase inhibitor specifically indicated for adult patients with advanced gastrointestinal stromal tumors who have previously received three or more kinase inhibitors.I. Indications and...
Contraindications and Medication in Special Populations of Ripretinib
Ripretinib does not list any absolute contraindications in its prescribing information, but there are clear usage restrictions or risks for specific physiological states and populations.I. Clear Contr...
Adverse Reactions of Ripretinib
Unlike traditional inhibition that targets the active site of a single kinase, ripretinib modulates the kinase "switch" conformation to suppress aberrant kinase signaling of KIT and PDGFRA, ...
Contraindications and Medication in Special Populations of Etoricoxib
Etoricoxib is effective for pain relief, but due to its cardiovascular and gastrointestinal risks, there are clear contraindications for its use.I. Absolute contraindications: who must not use it1. Al...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved